...
首页> 外文期刊>The journal of immunology >Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
【24h】

Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.

机译:使用表达细胞因子表达质粒的基于DNA的疫苗增强对丙型肝炎病毒核心蛋白的细胞和体液免疫反应。

获取原文

摘要

Development of a broad based cellular and humoral immune response to hepatitis C virus (HCV) structural proteins may be important for irradication of infection. DNA-based immunization is a promising approach to generate HCV-specific immune responses. Previous studies of DNA-based immunizations in mice using an HCV core DNA expression plasmid (pHCV2-2) demonstrated an efficient CTL response against HCV core epitopes; however, the humoral and Th cell proliferative responses were found to be weak. To enhance the immunogenicity of this nonsecreted viral structural protein at the B and T cell level, we coimmunized mice with pHCV2-2 and DNA expression constructs encoding for mouse IL-2, IL-4, and granulocyte-macrophage CSF proteins. Under these experimental conditions, a seroconversion frequency to anti-HCV core increased from 40 to 80% in immunized mice. The CD4+ inflammatory T cell proliferative responses as well as CD8+ CTL activity to HCV core protein were enhanced substantially after coimmunization with the IL-2 and granulocyte-macrophage CSF DNA expression constructs. In contrast, coimmunization with an IL-4-producing construct induced differentiation of Th cells toward a Th0 subtype and suppressed HCV core-specific CTL activity. Taken together, these studies emphasize that generation of antiviral immune responses using DNA-based immunization may be modified by local cytokine production at the site of Ag presentation.
机译:对丙型肝炎病毒(HCV)结构蛋白的广泛的细胞和体液免疫应答的发展对于消除感染很重要。基于DNA的免疫是产生HCV特异性免疫反应的一种有前途的方法。先前使用HCV核心DNA表达质粒(pHCV2-2)对小鼠进行的基于DNA免疫的研究表明,针对HCV核心抗原决定簇的CTL反应有效。然而,发现体液和Th细胞的增殖反应较弱。为了在B和T细胞水平上增强这种非分泌型病毒结构蛋白的免疫原性,我们用pHCV2-2和编码小鼠IL-2,IL-4和粒细胞巨噬细胞CSF蛋白的DNA表达构建体共同免疫了小鼠。在这些实验条件下,在免疫小鼠中,血清转化为抗HCV核心的频率从40%增加到80%。与IL-2和粒细胞巨噬细胞CSF DNA表达构建体共同免疫后,CD4 +炎性T细胞增殖反应以及对HCV核心蛋白的CD8 + CTL活性大大增强。相反,用产生IL-4的构建体进行共免疫可诱导Th细胞向Th0亚型分化,并抑制HCV核心特异性CTL活性。综上所述,这些研究强调使用基于DNA的免疫产生抗病毒免疫反应可能会因Ag呈递部位的局部细胞因子产生而改变。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号